4AB:ETR
AbbVie Common Stock
239,10 €
arrow_upward
+0,97%(+2,30) 1D
7-окт., 13:17:53 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
238,20 €
High
239,60 €
Low
238,00 €
Mkt. cap
473,30 млд
Avg. vol.
672,00
Volume
99,00
52-wk high
239,60 €
52-wk low
162,85 €
No. of employees
57 миң
Open
238,20 €
High
239,60 €
Low
238,00 €
Mkt. cap
473,30 млд
Avg. vol.
672,00
Volume
99,00
52-wk high
239,60 €
52-wk low
162,85 €
No. of employees
57 миң
News stories
From web sources and news partners
AD HOC NEWS
·
6 мүнөт мурун
AbbVie reports lymphoma trial success: AbbVie stock gains 2.25 percent
Investing.com
·
9 мүнөт мурун
AbbVie stock hits all-time high at 269.85 USD
Investing.com Canada
·
51 мүнөт мурун
AbbVie receives two FDA breakthrough designations for Temab-A By Investing.com
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
Sector-
Websiteabbvie.com